Weekly Digest – October 2026 Weekly Digest – October 2026 05 October 2026: Crescent Biopharma receives FDA IND clearance for CR-002 in Solid tumors Crescent Biopharma announced that the U.S. FDA has cleared the Investigational New Drug application for CR-002, […]